Allen Institute’s big new bet: $200M effort aims to go from mapping the brain to treating disease
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative…
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has made treating disease its goal. Read More
Read full article on GeekwireAI summaries can be wrong sometimes—always verify important details using the source article.
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNow